US Patent Issued to Karyopharm Therapeutics on Oct. 20 for "Uses of IL-12 as a replacement immunotherapeutic" (California Inventor)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,766,188, issued on Oct. 20, was assigned to Karyopharm Therapeutics Inc. (Newton, Mass.).

"Uses of IL-12 as a replacement immunotherapeutic" was invented by Lena A. Basile (Pasadena, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Aspects and embodiments of the present disclosure provide therapeutic methods comprising interleukin 12 (IL-12) as a replacement immunotherapeutic. The method comprises administering a physiological dose of exogenous IL-12 to a subject."

The patent was filed on July 18, 2017, under Application No. 16/318,670.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph...